期刊文献+

重视肝移植中脂肪肝供肝质量的评估的问题 被引量:1

原文传递
导出
摘要 1963年,美国的肝移植先驱Starzl教授实施了第一例人体原位肝移植,开创了人类器官移植历史的新篇章。历经40余年的蓬勃发展,肝移植治疗作为各种终末期肝病的有效手段已被广泛接受,外科技巧的提高和抗排斥反应策略的改进也使接受肝移植治疗的患者长期存活率得到显著提高。我国肝移植虽然起步较晚,但发展极为迅速,
作者 江艺 潘凡
出处 《中华普通外科学文献(电子版)》 2014年第4期1-2,共2页 Chinese Archives of General Surgery(Electronic Edition)
  • 相关文献

参考文献12

  • 1Starzal TE, Marchiuru TL, Vonkaulla Kn, et al. Hamutransplantatiun of the liver in humans[J]. Surg Gynecul Obstet, 1963, 117: 659-676.
  • 2Tarantino G, Saldalamacchia G, Conca P, et al. Nun-alcoholic fatty liver disease: further expression of the metabolic syndrome[J]..J Gastruenterol Hepatol, 2007, 22(3): 293-303.
  • 3范建高.第二讲 非酒精性脂肪肝的临床流行病学研究[J].中华消化杂志,2002,22(2):106-107. 被引量:284
  • 4Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation[J]. Liver Transpl, 2003, 9(7): 651-663.
  • 5Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation[J]. Transplant Proc, 1991, 23(1 PI 2): 1538-1540.
  • 6Spitzer AL, Lao OB, Dick AA, et al. The biopsied donor liver, incorporating macrosteatosis into high-risk donor assessment[J]. Liver Transpl, 2010, 16(7): 874-884.
  • 7Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvessicular fat safely expands the donor pool[J]. Transplantation, 1997, 64(2): 248- 251.
  • 8Ikegami T, Nishizaki T, Yanaga K, et al. Living-related auxiliary partial orthotopic liver transplantation for primary sclerosing ehonangitis-subsequent removal of the native liver[J]. Hepatogastroenterology, 1999, 46(29): 2951-2954.
  • 9叶啓发,明英姿,赵杰,彭贵主,张毅.64例脂肪变性供肝临床肝移植疗效分析[J].中华肝胆外科杂志,2013,19(2):105-107. 被引量:10
  • 10Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation[J]. Liver Transpl, 2003, 9(5): 500-505.

二级参考文献19

  • 1朱志军,高伟,孟醒初,张雅敏,蒋文涛,张建军,张玮晔,沈中阳.脂肪沉着供肝在肝脏移植中的应用[J].中华肝胆外科杂志,2005,11(9):627-629. 被引量:7
  • 2叶启发,牛英,明英姿,夏宗江,黄祖发.移植肝缺血-再灌注损伤程度的评估及其与肝移植患者预后的关系[J].中华器官移植杂志,2006,27(11):668-671. 被引量:6
  • 3D'Alessandro AM, Kalayoglu M, Sollinger H, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation,1991,51: 157-163.
  • 4Deborab V, Taras K, Dorotby P. et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl,2003,9: 500-505.
  • 5Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc, 1991,23 : 1538-1540.
  • 6Markin RS, Wisecarver JL, Radio SJ, et al. Frozen section evaluation of donor livers before transplantation. Transplantation, 1993,56 : 1403-1409.
  • 7Fishbein T, Fiel M, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation, 1997,64:248-251.
  • 8Chui A, Haghighi K, Painter D, et aL Donor fatty (steatotic)liver allografts in orthotopic liver transplantation. Transplant Proc.1999,31: 3286-3287.
  • 9Strasberg S, Howard T, Molmenti E, et al. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology, 1994,20 : 829-838.
  • 10Urena MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc, 1998,30 : 3288-3291.

共引文献297

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部